Literature DB >> 31524907

Recent progress on the total syntheses of macrocyclic diamine alkaloids.

Bichu Cheng1, Julius Reyes.   

Abstract

Covering: 2006 to 2019Macrocyclic diamine alkaloids derived from 3-alkyldihydropyridine dimers comprise a diverse and highly complex family of natural products. The macrocyclic and caged structural features of these alkaloids have inspired many creative solutions from the synthetic organic community over the past 30 years. This review will cover the successful synthetic campaigns over the past decade, with a focus on (1) key bond disconnections and advances and (2) remaining challenges and opportunities for innovation within this natural product class.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31524907     DOI: 10.1039/c9np00031c

Source DB:  PubMed          Journal:  Nat Prod Rep        ISSN: 0265-0568            Impact factor:   13.423


  4 in total

1.  Synthetic progress toward the marine natural product zamamiphidin A.

Authors:  Hao Wang; Di Tian; Zhaoxiang Meng; Zhihao Chen; Fei Xue; Xiao-Yu Liu; Hao Song; Yong Qin
Journal:  RSC Adv       Date:  2020-03-24       Impact factor: 4.036

2.  A New Organocatalytic Desymmetrization Reaction Enables the Enantioselective Total Synthesis of Madangamine E.

Authors:  Shinya Shiomi; Benjamin D A Shennan; Ken Yamazaki; Ángel L Fuentes de Arriba; Dhananjayan Vasu; Trevor A Hamlin; Darren J Dixon
Journal:  J Am Chem Soc       Date:  2022-01-17       Impact factor: 15.419

3.  A Unified Approach to Polycyclic Alkaloids of the Ingenamine Estate: Total Syntheses of Keramaphidin B, Ingenamine, and Nominal Njaoamine I.

Authors:  Zhanchao Meng; Simon M Spohr; Sandra Tobegen; Christophe Farès; Alois Fürstner
Journal:  J Am Chem Soc       Date:  2021-08-27       Impact factor: 15.419

4.  Total Synthesis Provides Strong Evidence: Xestocyclamine A is the Enantiomer of Ingenamine.

Authors:  Zhanchao Meng; Alois Fürstner
Journal:  J Am Chem Soc       Date:  2020-06-23       Impact factor: 15.419

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.